Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Calmy

Showing results (81-90 of 415) with videos related to

Pageof 42
Sort By:
Plos One|December 31, 2013
Persistent difficulties in switching to second-line ART in sub-saharan Africa--a systematic review and meta-analysisYoann Madec, Sandrine Leroy, Marie-Anne Rey-Cuille, et al.
AIDS (London, England)|December 29, 2004
Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-upAlexandra Calmy, Elise Klement, Roger Teck, et al.
AIDS (London, England)|March 21, 2003
Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapyAlexandra Calmy, Bernard Hirschel, Didier Hans, et al.
AIDS (London, England)|May 13, 2006
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohortAlexandra Calmy, Lorextu Pinoges, Elisabeth Szumilin, et al.
Medicine|August 10, 2020
Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case reportSanaz Lolachi, Sarah Morin, Matteo Coen, et al.
Journal of the International AIDS Society|November 14, 2014
Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approachDelphine Sculier, Laurence Toutous-Trellu, Charlotte Verolet, et al.
JAMA|July 20, 2010
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countriesMar Pujades-Rodríguez, Suna Balkan, Line Arnould, et al.
JAMA Dermatology|June 25, 2020
Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient With COVID-19Laurence Toutous Trellu, Gürkan Kaya, Chloé Alberto, et al.
Dermatology (Basel, Switzerland)|April 15, 2015
Hyaluronic Acid Filler in HIV-Associated Facial Lipoatrophy: Evaluation of Tissue Distribution and Morphology with MRIMinerva Becker, Nicolas Balagué, Xavier Montet, et al.
Revue Medicale Suisse|March 27, 2025
[Pharmaceutical challenges concerning Penicillin G : an example with the treatment of syphilis]Myriam Lamrayah, Soufiene Krifa, Mattéo Reymond, et al.
Pageof 42

Showing results (81-90 of 415) with videos related to

Sort By:
Pageof 42
Plos One|December 31, 2013
Persistent difficulties in switching to second-line ART in sub-saharan Africa--a systematic review and meta-analysisYoann Madec, Sandrine Leroy, Marie-Anne Rey-Cuille, et al.
AIDS (London, England)|December 29, 2004
Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-upAlexandra Calmy, Elise Klement, Roger Teck, et al.
AIDS (London, England)|March 21, 2003
Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapyAlexandra Calmy, Bernard Hirschel, Didier Hans, et al.
AIDS (London, England)|May 13, 2006
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohortAlexandra Calmy, Lorextu Pinoges, Elisabeth Szumilin, et al.
Medicine|August 10, 2020
Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case reportSanaz Lolachi, Sarah Morin, Matteo Coen, et al.
Journal of the International AIDS Society|November 14, 2014
Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approachDelphine Sculier, Laurence Toutous-Trellu, Charlotte Verolet, et al.
JAMA|July 20, 2010
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countriesMar Pujades-Rodríguez, Suna Balkan, Line Arnould, et al.
JAMA Dermatology|June 25, 2020
Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient With COVID-19Laurence Toutous Trellu, Gürkan Kaya, Chloé Alberto, et al.
Dermatology (Basel, Switzerland)|April 15, 2015
Hyaluronic Acid Filler in HIV-Associated Facial Lipoatrophy: Evaluation of Tissue Distribution and Morphology with MRIMinerva Becker, Nicolas Balagué, Xavier Montet, et al.
Revue Medicale Suisse|March 27, 2025
[Pharmaceutical challenges concerning Penicillin G : an example with the treatment of syphilis]Myriam Lamrayah, Soufiene Krifa, Mattéo Reymond, et al.
Pageof 42